FDA Inspection 1081592 — Albemarle US, Inc.
The FDA completed an inspection of Albemarle US, Inc. on January 25, 2019 in Kings Mountain, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 25, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Kings Mountain, NC (United States)